Abridge Inks Strategic Deals with Eli Lilly and Nvidia
Abridge, a healthcare artificial intelligence company, has announced new strategic partnerships with pharmaceutical giant Eli Lilly and chipmaker Nvidia. Eli Lilly has made a strategic investment in Abridge, while Nvidia will collaborate with the company to develop a foundational AI model specifically designed for clinical conversations. These agreements aim to strengthen Abridge's competitive position in the market for software that supports medical professionals and streamlines hospital operations.
Healthcare artificial intelligence firm Abridge recently announced new deals with Eli Lilly and Nvidia. The company, which provides software that supports doctors and streamlines hospital billing and operations, aims to enhance its market standing through these collaborations.
Eli Lilly has made a strategic investment in Abridge, while Nvidia will partner with the company to develop what is described as "the first foundation model purpose-built for clinical conversations." These announcements were made by Abridge CEO Shiv Rao at an event in midtown Manhattan.
Abridge's platform is designed to document patient visits and offer guidance and suggestions to clinicians at various stages of patient interaction. The company's technology is currently utilized by hundreds of health systems.
According to STAT News, these partnerships reflect Abridge's strategy to gain an edge in the competitive healthcare AI market.
Advertisement
AdSense slot • inline
